Stress responses involving the Akt pathway can become dominant in cases with pancreatic cancer complicated by high levels of circulating GDF-15, providing biological validation for a cut-off for serum GDF-15 in pancreatic cancer. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.